CD74+CCL5+效应体 CD8+ T 细胞驱动粘膜炎症,并预测炎症性肠病中的生物反应
Shanshan Wu1, Shuangchun Liu1, Caixia Zhang1
1The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong Province, 510630, China.
Journal of translational medicine
|November 29, 2025
概括
炎症性肠病 (IBD) 涉及结肠中CCL5+ CD8+ T细胞升高,导致炎症. 包括FKBP11在内的六个基因签名可以预测IBD诊断和治疗反应.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 遗传学 遗传学 是一个
背景情况:
- 炎症性肠病 (IBD) 呈现出各种各样的炎症和对生物药物的反应.
- 识别关键的免疫细胞和分子驱动因素对于理解IBD病原体至关重要.
- 开发治疗结果的预测生物标志物仍然是一个重大挑战.
研究的目的:
- 识别免疫细胞子集和驱动IBD病变的分子程序.
- 开发用于IBD治疗结果的预测生物标志物.
- 描述IBD中的免疫微生物相互作用.
主要方法:
- 在IBD队列中整合单细胞RNA测序,转录基因解卷,GWAS和微生物组概况.
- 与临床表型和治疗反应相关的免疫微生物相互作用的系统性表征.
- 使用免疫组织化学和流细胞计验证关键标记物 (CCL5,CD8+T细胞).
主要成果:
- 鉴定出CCL5+效应体CD8+T细胞是结肠炎症的关键调解者,具有高的促炎活性.
- 在IBD结肠组织中证实了CCL5表达的升高和CD8+T细胞的透.
- 一个六个基因的签名 (包括FKBP11) 显示出预测IBD诊断和infliximab反应的潜力,与疾病严重程度相关联.
结论:
- 在IBD结肠组织中,CCL5+ CD8+ T细胞显著丰富,通过促炎途径驱动炎症.
- 一个六基因模型,特别是涉及FKBP11,显示IBD分层和预测infliximab反应的希望.
- 这些发现强调了IBD中免疫和微生物因素的重要性,需要进一步验证.
更多相关视频
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
3.1K
06:57Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
9.5K
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
457
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
457
01:29Inflammatory Bowel Disease IV: Pharmacological Management
450
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
450
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
862
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
862
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
461
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
461
01:24T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
01:30Inflammatory Bowel Disease II: Crohn's Disease
925
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
925